This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Retinoblastoma, Cataracts Infantile, Glaucoma, Congenital or Leucocoria
and you are
under 7
years old
The phase for this study is not defined.
Show me locations

The purpose

This study seeks to determine whether a smartphone application called CRADLE (ComputeR Assisted Detection of LEukocoria) has the potential to improve the detection of leukocoria. There will be no impact on participants' health outcome. This study will be performed in two parts, each with a distinct cohort of patients. Part 1 will assess the feasibility of various techniques/conditions for using CRADLE within patients known to have leukocoria. Part 2 will estimate the sensitivity and specificity of CRADLE to detect leukocoria (using the techniques selected from information gathered in Part 1) as compared to an ophthalmoscope, within patients referred to the clinic for suspected leukocoria. PRIMARY OBJECTIVES: - To determine the most effective usage of a camera phone application (CRADLE) to maximize detection of leukocoria in patients with retinoblastoma, congenital cataracts, and glaucoma. - To estimate the sensitivity and specificity of a camera phone application (CRADLE) in detecting leukocoria.

Provided treatments

  • Other: CRADLE
  • Other: Red reflex testing

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03016156. The sponsor of the trial is St. Jude Children's Research Hospital and it is looking for 290 volunteers for the current phase.
Official trial title:
Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma